Cost-Effectiveness Of Boceprevir Therapy In Adult Patients With Chronic Hepatitis C (Hcv) Genotype 1

Value in Health ◽

10.1016/j.jval.2013.03.440 ◽

2013 ◽

Vol 16 (3) ◽

pp. A94 ◽

Author(s):

P. Mernagh ◽

J. Feng ◽

M Del Cuore

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Adult Patients ◽

Hcv Genotype ◽

Download Full-text

P1167 rs12979860 IL28B GENOTYPE IS ASSOCIATED WITH ADVANCED FIBROSIS IN HCV GENOTYPE 1-INFECTED EUROPEAN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS FROM THE INTERNATIONAL GEN-C STUDY

Journal of Hepatology ◽

10.1016/s0168-8278(14)61327-1 ◽

2014 ◽

Vol 60 (1) ◽

pp. S473

Author(s):

A. Mangia ◽

V. De Ledinghen ◽

F. Bailly ◽

J. Brahm ◽

J. Keiss ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Il28b Genotype ◽

Advanced Fibrosis ◽

Hcv Genotype ◽

Download Full-text

Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2009.01157.x ◽

2010 ◽

Vol 17 (2) ◽

pp. 139-147 ◽

Author(s):

M. Rodriguez-Torres ◽

M. S. Sulkowski ◽

R. T. Chung ◽

F. M. Hamzeh ◽

D. M. Jensen

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virologic Response ◽

Early Virologic Response ◽

Hcv Genotype ◽

Factors Associated ◽

Hcv Genotype 1 ◽

Peginterferon Alfa

Download Full-text

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

Journal of Viral Hepatitis ◽

10.1111/jvh.12289 ◽

2014 ◽

Vol 22 (3) ◽

pp. 254-262 ◽

Author(s):

T. Oze ◽

N. Hiramatsu ◽

T. Yakushijin ◽

R. Yamada ◽

N. Harada ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Side Effects ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Hcv Genotype ◽

The Real ◽

Hcv Genotype 1 ◽

Chronic Hepatitis C Patients

Download Full-text

332 Peginterferon alfa-2A (40KD) (PEGASYS®) in combination with ribavirin in African American and Caucasian patients with chronic hepatitis C HCV genotype 1: safety and tolerability

10.1016/s0270-9139(03)80375-0 ◽

2003 ◽

Vol 38 ◽

pp. 319-319 ◽

Author(s):

C HOWELL ◽

L JEFFERS ◽

W CASSIDY ◽

K RAJENDERREDDY ◽

S SHERIDAN ◽

...

Keyword(s):

African American ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Hcv Genotype ◽

Caucasian Patients ◽

Hcv Genotype 1 ◽

Peginterferon Alfa

Download Full-text

Long-Term Outcomes of Ledipasvir/Sofosbuvir (LDV/ SOF) for the Treatment of Chronic Hepatitis C Infected (HCV) Genotype 1 Patients in the UK

Value in Health ◽

10.1016/j.jval.2014.08.2507 ◽

2014 ◽

Vol 17 (7) ◽

pp. A675

Author(s):

I. Guerra ◽

L. Marie ◽

S. Cure

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Long Term Outcomes ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Download Full-text

SAFETY OF OMBITASVIR/PARITAPREVIR/RITONAVIR+DASABUVIR IN CHRONIC HEPATITIS C PATIENTS WITH HCV GENOTYPE 1 INFECTION

Acta Poloniae Pharmaceutica - Drug Research ◽

10.32383/appdr/105681 ◽

2019 ◽

Vol 76 (4) ◽

pp. 613-620

Author(s):

Tomasz Tatara ◽

Marta Dąbrowska-Bender ◽

Anna Staniszewska ◽

Aneta Duda-Zalewska

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Hcv Genotype ◽

Hcv Genotype 1 ◽

Chronic Hepatitis C Patients

Download Full-text

328 Comparison of 48 or 72 weeks of treatment with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive patients with chronic hepatitis C infected with HCV genotype 1

10.1016/s0270-9139(03)80371-3 ◽

2003 ◽

Vol 38 ◽

pp. 317-317 ◽

Author(s):

T BERG ◽

M VONWAGNER ◽

H HINRICHSEN ◽

T HEINTGES ◽

P BUGGISCH ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Hcv Genotype ◽

Treatment Naïve ◽

Hcv Genotype 1 ◽

Peginterferon Alfa

Download Full-text

Faculty Opinions recommendation of Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718367587.793494880 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Download Full-text

Cost-effectiveness of treating Hepatitis C Virus (HCV) Genotype 1 (GT1) patients with abbvie 3D (Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir) +/- ribavirin compared to harvoni (Sofosbuvir/Ledipasvir) in the United States

Value in Health ◽

10.1016/j.jval.2015.03.1307 ◽

2015 ◽

Vol 18 (3) ◽

pp. A225 ◽

Author(s):

S. Johnson ◽

H. Parise ◽

S. Virabhak ◽

T. Juday ◽

D. Misurski ◽

...

Keyword(s):

United States ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

The United States ◽

Hcv Genotype ◽

Download Full-text

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options

Journal of Viral Hepatitis ◽

10.1111/jvh.12278 ◽

2014 ◽

Vol 22 (2) ◽

pp. 175-183 ◽

Author(s):

P. A. Cortesi ◽

A. Ciaccio ◽

M. Rota ◽

J. K. Lim ◽

S. De Salvia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Options ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Treatment Naïve

Download Full-text